Ansell Limited (ASX:ANN)
29.81
+0.22 (0.74%)
Apr 10, 2026, 4:10 PM AEST
Ansell Market Cap
Ansell has a market cap or net worth of 4.19 billion as of April 10, 2026. Its market cap has decreased by -15.84% in one year.
Market Cap
4.19B
Enterprise Value
5.11B
Revenue
3.01B
Ranking
n/a
PE Ratio
21.40
Stock Price
29.81
Market Cap Chart
Since January 16, 1992, Ansell's market cap has decreased from 5.00B to 4.19B, a decrease of -16.19%. That is a compound annual growth rate of -0.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2026 | 4.19B | -16.07% |
| Dec 31, 2025 | 4.99B | 1.96% |
| Dec 31, 2024 | 4.89B | 56.70% |
| Dec 29, 2023 | 3.12B | -12.08% |
| Dec 30, 2022 | 3.55B | -11.25% |
| Dec 31, 2021 | 4.00B | -10.48% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 67.28B |
| Sigma Healthcare | 31.06B |
| Pro Medicus | 13.31B |
| Cochlear | 11.34B |
| Sonic Healthcare | 9.82B |
| Ramsay Health Care | 9.29B |
| Telix Pharmaceuticals | 4.62B |
| 4DMedical | 3.71B |